Disease Models & Mechanisms · 8 authors, 9 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Researchers overexpressed 163 human chromosome 21 genes in mouse cell lines to identify those that modulate Sonic hedgehog signaling, a pathway implicated in Down syndrome. They found four genes that inhibit the SHH-dependent proliferation of cerebellar granule cell precursors.
The study performed an overexpression screen of 163 human chromosome 21 cDNAs in SHH-responsive mouse cell lines to identify genes that modulate SHH signaling, which is disrupted in Down syndrome. Validation in cerebella of Ts65Dn and TcMAC21 mice confirmed trisomic candidate gene overexpression. The screen identified four genes (B3GALT5, ETS2, HMGN1, and MIS18A) that inhibit SHH-dependent proliferation of primary cerebellar granule cell precursors. Other genes, like DYRK1A, upregulated SHH signaling. Limitations include the inability of cDNA overexpression to recapitulate the full genetic context of trisomy, potential for supraphysiological expression, and the use of mouse cell lines which may not fully model human development. The findings prioritize dosage-sensitive chromosome 21 genes for further study and suggest potential therapeutic avenues for Down syndrome.
